2) Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000 ; 62 : 299-307
3) Grotz W, Rasenack J, Benzing T, et al. Occurrence and management of hepatitis B virus reactivation following kidney transplantation. Clin Nephrol 1998 ; 49 : 385-8
4) Shibolet O, Ilan Y, Gillis S, et al. Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood 2002 ; 100 : 391-6
5) Idilman R, Arat M, Soydan E, et al. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat 2004 ; 11 : 141-7